Searched for
ALEMBIC PHARMACEUTICALS NEWS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stocks in news: Adani Enterprises, Tata Motors PV, Tata Steel, Jio Financial, ITC HotelsMarkets extended their rebound for a second consecutive session on Thursday, buoyed by supportive global cues and selective buying in heavy...
- Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC LifeMarkets ended flat on Thursday after a volatile session, with analysts maintaining a positive outlook and recommending a buy-on-dips strate...
- Stocks in news: IRFC, Voltas, IDFC First Bank, Alembic Pharma, LupinMarkets declined sharply on Tuesday due to weak global cues, with the Nifty retesting crucial support near 25,400. Several stocks like IRFC...
- Alembic Pharmaceuticals shares rise 2% after USFDA nod for key hypertension drugOn Monday, Alembic Pharmaceuticals saw a surge in its stock prices after the USFDA greenlit its Diltiazem Hydrochloride Tablets, a crucial ...
- Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tabletsAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major...
- Stocks in news: Ambuja Cement, Alivus Life, Route Mobile, Aurobindo Pharma, LTIMindtreePiramal Enterprises announced that the administrative committee of its board of directors will meet on December 20 to consider public issua...
- Stocks in news: Ultratech, Paytm, L&T, Biocon, Alembic PharmaLarsen and Toubro (L&T) has overturned a Rs 702 crore customs duty demand following a favourable ruling from the Central Excise & Service T...
- Alembic gets USFDA nod for generic skin treatment creamThe approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US LL...
- Add Alembic Pharmaceuticals, target price Rs 695: ICICI SecuritiesAlembic Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Royalty Income and Other Operating R...
- Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...
- Reduce Alembic Pharmaceuticals, target price Rs 641: ICICI SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 13347.62 Crore) operating in P...
- Neutral on Alembic Pharmaceuticals, target price Rs 750: Motilal Oswal Financial ServicesAlembic Pharma delivered a better than expected operational performance, led by better-than-industry growth in the Domestic Formulations (D...
- Buy Alembic Pharmaceuticals, target price Rs 820: Yes SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 15335.85 Crore) operating in P...
- Alembic Pharma tanks 10% after flop show in Q1Shares of Alembic Pharmaceuticals declined 10 per cent to Rs 822.60, its new 52-week low, on Tuesday.
- US FDA finds quality control, equipment issues at Alembic Pharma unitEarlier this month, the US drug regulator had issued a ‘Form 483’ to the facility of the drug company with five observations.
- Add Alembic Pharmaceuticals, target price Rs 1151: ICICI SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 18770.80 Crore) operating in P...
- Buy Alembic Pharmaceuticals, target price Rs 1180: Yes SecuritiesAlembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 19440.09 Crore) operating in P...
- Alembic Pharma raises Rs 350 crore via NCDsThe co said it has also allotted 2,000, 9% rated unsecured listed redeemable NCDs
Load More
